Penbrook Management LLC Mesoblast LTD Transaction History

Penbrook Management LLC

$145 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$1.22 - $4.83 $36,234 - $143,451	29,700 Added 11.62%	285,350 $350,000
Q2 2022 Jul 29, 2022	SELL	$2.22 - $4.54 $444 - $908	-200 Reduced 0.08%	255,650 $568,000
Q4 2021 Jan 10, 2022	BUY	$4.17 - $7.09 $39,198 - $66,646	9,400 Added 3.81%	255,850 $1.23 Million
Q3 2021 Oct 26, 2021	SELL	$5.87 - $7.85 $9,979 - $13,345	-1,700 Reduced 0.69%	246,450 $1.48 Million
Q2 2021 Jul 27, 2021	BUY	$6.69 - $9.0 $11,373 - $15,300	1,700 Added 0.69%	248,150 $1.86 Million
Q1 2021 May 05, 2021	SELL	$8.26 - $11.4 $33,040 - $45,600	-4,000 Reduced 1.6%	246,450 $2.04 Million
Q1 2021 Apr 16, 2021	BUY	$8.26 - $11.4 $23,954 - $33,060	2,900 Added 1.17%	250,450 $1.1 Million
Q4 2020 Jan 27, 2021	SELL	$8.21 - $18.59 $2,463 - $5,577	-300 Reduced 0.12%	247,550 $2.1 Million
Q3 2020 Oct 23, 2020	BUY	$11.33 - $19.81 $230,565 - $403,133	20,350 Added 8.95%	247,850 $4.61 Million
Q2 2020 Jul 28, 2020	SELL	$4.2 - $15.45 $5,460 - $20,085	-1,300 Reduced 0.57%	227,500 $2.59 Million
Q1 2020 Apr 14, 2020	SELL	$3.38 - $10.63 $11,154 - $35,079	-3,300 Reduced 1.42%	228,800 $1 Million
Q4 2019 Jan 16, 2020	BUY	$5.74 - $7.42 $50,512 - $65,296	8,800 Added 3.94%	232,100 $1.71 Million
Q3 2019 Oct 11, 2019	SELL	$4.68 - $7.42 $7,488 - $11,872	-1,600 Reduced 0.71%	223,300 $1.55 Million
Q2 2019 Jul 15, 2019	BUY	$4.67 - $5.88 $2,802 - $3,528	600 Added 0.27%	224,900 $1.2 Million
Q1 2019 Apr 24, 2019	SELL	$4.19 - $5.25 $69,554 - $87,150	-16,600 Reduced 6.89%	224,300 $1.18 Million
Q4 2018 Feb 01, 2019	BUY	$3.51 - $8.6 $49,140 - $120,400	14,000 Added 6.17%	240,900 $993,000
Q3 2018 Oct 23, 2018	SELL	$5.75 - $8.16 $62,675 - $88,944	-10,900 Reduced 4.58%	226,900 $1.85 Million
Q1 2018 Apr 27, 2018	SELL	$4.91 - $7.72 $142,390 - $223,880	-29,000 Reduced 10.87%	237,800 $1.37 Million
Q4 2017 Feb 21, 2018	BUY	$4.91 - $7.23 $1.31 Million - $1.93 Million	266,800	266,800 $1.56 Million

Others Institutions Holding MESO

# of Institutions

Shares Held

151K

Call Options Held

Put Options Held

View Full List

About MESOBLAST LTD

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

More about MESO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penbrook Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penbrook Management LLC with notifications on news.

Account